Through the programme of Commissions, The Lancet editors work with academic partners to identify the most pressing issues in science, medicine, and global health, with the aim of providing recommendations that change health policy, improve practice, and enhance cancer control.
Ambition and aims
The Lancet Oncology Commission will examine the challenges that impede progress in precision oncology, both from a research and implementation perspective, and will propose potential solutions to assist health systems worldwide deliver equitable, effective and sustainable molecular-based cancer care, to improve patient outcomes, reduce health disparities, accelerate research, and, in general, to enhance global cancer control. Several challenges of delivering precision oncology will be addressed, including: implementation, access, and sustainability; data collection and responsible data sharing; data protection and patient privacy; use of artificial intelligence in the management of big data and related ethical issues; patient/provider education; and the roles of health systems, payers, and regulators.
Read the aims in more detail in the Lancet Oncology Article.
Stay tuned for more news shortly!